Open access
Aug 2026
Prognostic risk modeling based on integrated multi-omics analysis identifies CRY2 as a key regulator in tumor immunity and patient survival in colorectal cancer
A ferroptosis- and lipid metabolism-related prognostic signature is developed that accurately predicts survival outcomes and immune characteristics in CRC and CRY2 was identified as a critical regulator of tumor growth.
Yu Guo, Yongbo Zou, Min Wang
· Annals medicus · 0 citations